DE69025515D1 - Phosphorilierte Prodrugs als Glycosidase-Inhibitoren - Google Patents

Phosphorilierte Prodrugs als Glycosidase-Inhibitoren

Info

Publication number
DE69025515D1
DE69025515D1 DE69025515T DE69025515T DE69025515D1 DE 69025515 D1 DE69025515 D1 DE 69025515D1 DE 69025515 T DE69025515 T DE 69025515T DE 69025515 T DE69025515 T DE 69025515T DE 69025515 D1 DE69025515 D1 DE 69025515D1
Authority
DE
Germany
Prior art keywords
prodrugs
phosphorilated
glycosidase inhibitors
glycosidase
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69025515T
Other languages
English (en)
Other versions
DE69025515T2 (de
Inventor
Peter Richard Scudder
Raymond Allen Dwek
Thomas William Rademacher
Gary Steven Jacob
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Application granted granted Critical
Publication of DE69025515D1 publication Critical patent/DE69025515D1/de
Publication of DE69025515T2 publication Critical patent/DE69025515T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings
DE69025515T 1989-08-17 1990-08-13 Phosphorilierte Prodrugs als Glycosidase-Inhibitoren Expired - Fee Related DE69025515T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/394,914 US5043273A (en) 1989-08-17 1989-08-17 Phosphorylated glycosidase inhibitor prodrugs

Publications (2)

Publication Number Publication Date
DE69025515D1 true DE69025515D1 (de) 1996-04-04
DE69025515T2 DE69025515T2 (de) 1996-10-02

Family

ID=23560918

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69025515T Expired - Fee Related DE69025515T2 (de) 1989-08-17 1990-08-13 Phosphorilierte Prodrugs als Glycosidase-Inhibitoren

Country Status (9)

Country Link
US (1) US5043273A (de)
EP (1) EP0413674B1 (de)
JP (1) JPH0791309B2 (de)
AT (1) ATE134639T1 (de)
CA (1) CA2023404C (de)
DE (1) DE69025515T2 (de)
DK (1) DK0413674T3 (de)
ES (1) ES2084019T3 (de)
GR (1) GR3019753T3 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252587A (en) * 1990-04-27 1993-10-12 Merrell Dow Pharmaceuticals, Inc. N-derivatives of 1-deoxy nojirimycin
US5536732A (en) * 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
EP0453692A1 (de) * 1990-04-27 1991-10-30 Merrell Dow Pharmaceuticals Inc. Neue Nojirimycin-Derivate
GB9602080D0 (en) * 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
WO1999029321A1 (en) 1997-12-11 1999-06-17 The Chancellor, Masters And Scholars Of The University Of Oxford Inhibition of membrane-associated viral replication
US6465488B1 (en) 1997-12-11 2002-10-15 Chancellor, Masters & Scholars Of The University Of Oxford Inhibition of glycolipid biosynthesis
US6274597B1 (en) 1998-06-01 2001-08-14 Mount Sinai School Of Medicine Of New York University Method of enhancing lysosomal α-Galactosidase A
JP2003506406A (ja) 1999-08-10 2003-02-18 ザ・チャンセラー・マスターズ・アンド・スカラーズ・オブ・ザ・ユニバーシティ・オブ・オックスフォード 長鎖ｎ−アルキル化合物およびそのオキサ誘導体
US7256005B2 (en) 1999-08-10 2007-08-14 The Chancellor, Masters And Scholars Of The University Of Oxford Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
JP5107350B2 (ja) 2005-06-08 2012-12-26 アミカス セラピューティックス インコーポレイテッド イミノおよびアミノ糖の精製
CN101600475A (zh) 2005-07-27 2009-12-09 佛罗里达大学研究基金会有限公司 修正蛋白质错误折叠的小型化合物及其使用
JP4644287B2 (ja) 2005-12-27 2011-03-02 大塚製薬株式会社 水溶性ベンゾアゼピン化合物及び医薬組成物
EP2399587A1 (de) 2006-08-02 2011-12-28 The University of Oxford Liposomenbehandlung von Virusinfektionen
CA2666814A1 (en) * 2006-08-21 2008-05-29 United Therapeutics Corporation Combination therapy for treatment of viral infections
EP1995323A1 (de) * 2007-05-24 2008-11-26 Libragen Verfahren zur Herstellung von C-6-phosphorylierten D-Aldohexosen und C-6-phosphorylierten D-Aldohexosederivaten
EP2282723A2 (de) * 2008-03-26 2011-02-16 University of Oxford Liposome mit endoplasmischem retikulum als target
KR20120042716A (ko) 2009-02-23 2012-05-03 유나이티드 세러퓨틱스 코오포레이션 이미노슈가 및 바이러스성 질환을 치료하는 방법
JP5951996B2 (ja) * 2009-02-24 2016-07-13 ユナイテッド セラピューティクス コーポレーション イミノ糖及びアレナウイルス感染症を治療する方法
CN102427804A (zh) * 2009-03-27 2012-04-25 牛津大学之校长及学者 降低胆固醇水平的脂质体
WO2010135731A1 (en) * 2009-05-22 2010-11-25 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
EP2440205B1 (de) 2009-06-12 2014-08-27 United Therapeutics Corporation Iminozucker zur verwendung in der behandlung von bunyaviralen und togaviralen erkrankungen
IN2012DN00352A (de) 2009-06-16 2015-08-21 Bikam Pharmaceuticals Inc
EP2473046B1 (de) 2009-09-04 2014-10-22 United Therapeutics Corporation Iminozucker zur verwendung in der behandlung von filoviruserkrankungen
CA2772807A1 (en) * 2009-09-04 2011-03-10 The Chancellor, Masters And Scholars Of The University Of Oxford Methods of treating poxviral infections
BR112012004676A2 (pt) * 2009-09-04 2019-09-24 United Therapeutics Corp método de tratar infecções orotomixovirais.
US20110136868A1 (en) * 2009-12-07 2011-06-09 University Of Oxford Agents for inhibiting osteoclastogenesis and/or osteoclast activation
EA032666B1 (ru) 2011-06-14 2019-06-28 Бикам Фармасьютикалз, Инк. Опсинсвязывающие лиганды и способы их применения
EP2768307B1 (de) 2011-10-19 2020-03-18 Bikam Pharmaceuticals, Inc. Opsinbindende liganden, zusammensetzungen damit und anwendungsverfahren dafür
US9353063B2 (en) 2011-11-30 2016-05-31 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
CA2862746A1 (en) 2011-12-01 2013-06-06 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
JP5876856B2 (ja) * 2013-08-02 2016-03-02 中国医学科学院薬物研究所 血糖降下剤を調製するための、桑の枝由来のアルカロイドの有効画分の使用
RU2702133C2 (ru) 2013-09-16 2019-10-04 ЭМЕРГЕНТ ВИРОЛОДЖИ ЭлЭлСи Производные дезоксинойиримицина и способы их применения
EP3215499B1 (de) 2014-11-05 2021-01-20 Emergent Virology LLC Iminozucker zur verwendung in der behandlung von virenerkrankungen
WO2017192599A1 (en) 2016-05-02 2017-11-09 Florida State University Research Foundation, Inc. Treatment of zika virus infections using alpha-glucosidase inhibitors
WO2017220298A1 (en) * 2016-06-22 2017-12-28 Unilever N.V. Edible fat-continuous emulsion comprising 1-deoxynojirimycin and lecithin
EP3318277A1 (de) 2016-11-04 2018-05-09 Institut du Cerveau et de la Moelle Epiniere-ICM Inhibitoren der glucosylceramidsynthase zur behandlung von motoneuronerkrankungen
WO2021168483A2 (en) 2020-02-21 2021-08-26 Florida State University Research Foundation, Inc. Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
DE2839309A1 (de) * 1978-09-09 1980-03-27 Bayer Ag 3,4,5-trihydroxypiperidin-derivate
US4847244A (en) * 1985-09-17 1989-07-11 Burroughs Wellcome Co. Treatment of human viral infections
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US4849430A (en) * 1988-03-09 1989-07-18 Monsanto Company Method of inhibiting virus
US4999360A (en) * 1987-12-21 1991-03-12 Monsanto Company Method of inhibiting virus

Also Published As

Publication number Publication date
EP0413674A3 (en) 1991-07-17
CA2023404A1 (en) 1991-02-18
DE69025515T2 (de) 1996-10-02
CA2023404C (en) 2001-10-23
JPH03118327A (ja) 1991-05-20
ATE134639T1 (de) 1996-03-15
JPH0791309B2 (ja) 1995-10-04
EP0413674A2 (de) 1991-02-20
ES2084019T3 (es) 1996-05-01
DK0413674T3 (da) 1996-06-10
EP0413674B1 (de) 1996-02-28
GR3019753T3 (en) 1996-07-31
US5043273A (en) 1991-08-27

Similar Documents

Publication Publication Date Title
DE69025515D1 (de) Phosphorilierte Prodrugs als Glycosidase-Inhibitoren
ES2038251T3 (es) Un procedimiento para producir un derivado de benzamida.
FR2387945A1 (fr) Agents favorisant la croissance des plantes et phytoprotecteurs a base d'oximethers et d'oximesters
DE3873007T2 (de) Kathartica.
FI895447A0 (fi) Substituerade adeninderivat anvaendbara som terapeutiska substanser.
FR2401148A1 (fr) Procede de preparation de 1-amino-3-aryloxy-2-propanols
FR2381733A1 (fr) Procede de preparation de m-bromo-a,a,a-trifluorotoluenes
ES2074440T3 (es) Isomeros opticos de un derivado de espiroquinuclidina.
FR2631570B1 (fr) Procede d'usinage de pignons arbres par rectification des centres
FR2514006B1 (de)
ES2108004T3 (es) Nuevas alquil piperidinas sustituidas y su empleo como inhibidores de la sintesis de colesterol.
FR2483948B1 (fr) Production de l-proline par fermentation
SE8803765L (sv) Nya isopolypeptider samt foerfarande foer framstaellning av desamma
FR2446841A1 (fr) Procede de preparation de 1a,3b-dihydroxy-d5-steroides
ATE60779T1 (de) N-glykolylneuraminsaeurederivat.
FR2383920A1 (fr) Procede de preparation d'un derive d'acetonitrile et derive obtenu par ce procede
ES2051767T3 (es) Cetorreduccion estereoespecifica de esteres de acido carboxilico-biciclooctanodiona por microorganismos.
DK0408053T3 (da) Monocycliske terpenderivater
FI102274B1 (fi) Menetelmä optisesti aktiivisen syklobutanonin valmistamiseksi, joka on välituote optisesti aktiivisen syklobutaaninukleosidin valmistuksessa, sekä menetelmässä käyttökelpoinen välituote
ES2067468T3 (es) Secuencia de reaccion de adicion en 1,2-1,4 para dar difenilacetilenos.
IT211843Z2 (it) Produzione di piastre. cilindro per un impianto di
HU911945D0 (en) Process for the production of intermediers of anti dopamin-betha-hydroxylase
FR2453159A1 (fr) Procede de preparation de 2-aminopyrazines substituees
FR2367770A1 (fr) Procede de preparation d'acides alcenylphosphiniques
ES2011309A6 (es) Procedimiento para preparar nuevas benzo(g)quinolinas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee